exploring neoadjuvant egfr-tkis in lung cancer
Published 2 years ago • 103 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:33
neoadjuvant egfr tki trials in nsclc
-
1:41
efficacy of dual egfr and met inhibition in nsclc post egfr tki failure
-
2:28
clinical trials of neoadjuvant targeted therapy in resectable nsclc
-
1:47
the development of surgery for lung cancer with the evolution of neoadjuvant/adjuvant treatment
-
1:09
current and novel treatment approaches for first-line egfr-m nsclc
-
0:49
exploring advantages to third-generation tkis in lung cancer
-
2:56
non-tki-based treatment options for egfr-mutant lung cancer
-
0:54
surgical endpoints are needed in lung cancer trials of neoadjuvant therapy
-
2:43
rezilient1: zipalertinib, a novel egfr tki, in nsclc with ex20ins mutations
-
1:51
future directions for neoadjuvant immunotherapy in lung cancer
-
0:48
assessing efgr tkis in patients with wild-type efgr nsclc
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
1:48
acquired resistance to third-generation egfr tkis in nsclc
-
0:56
nautika1: safety and tolerability of neoadjuvant alectinib in alk-positive nsclc
-
1:02
early intervention neoadjuvant immunotherapy in lung cancer
-
2:21
osimertinib ipilimumab in egfr-mutated nsclc
-
0:55
flowers: osimertinib and savolitinib in met aberrant, egfrm nsclc
-
1:31
squat: neoadjuvant chemo-immuno-radiation and surgery in nsclc
-
4:08
targeted therapies in lung cancer